PURPOSE: Health-related quality of life (HRQoL) is important for long-term social functioning. It is considerably reduced in patients with depression. We studied the impact of HRQoL on treatment outcome in patients with unipolar depression. Furthermore, we analysed factors associated with HRQoL in inpatients with unipolar depression. METHODS: One hundred and eighty patients suffering from major depressive disorder were evaluated during their inpatient treatment by assessing admission and discharge depression severity and their HRQoL, using the Medical Outcomes Study 12-item Short Form (SF-12). Baseline and treatment variables associated with HRQoL were examined by regression analysis. Primary outcome measures were the Hamilton Rating Scale and the Beck Depression Inventory. RESULTS: HRQoL improved significantly during inpatient treatment. Lower HRQoL outcomes were strongly associated with higher age, somatic comorbidities, a recurrent depressive disorder and stronger depressive symptoms at admission. Additionally, patients with a complex treatment situation (high number of medications, antidepressant switch) showed stronger impairment of HRQoL. Personality disorders and additional psychotherapy did not predict HRQoL. CONCLUSION: The inpatient treatment resulted in an increase of the SF-12 scores, although to a lower extent than depressive symptoms. Several factors negatively influence HRQoL, such as the presence of somatic and axis I psychiatric comorbiditites and a recurrent or severe depressive episode. Targeting somatic comorbidities in patients with unipolar depression seem to play an important role for HRQoL.
PURPOSE: Health-related quality of life (HRQoL) is important for long-term social functioning. It is considerably reduced in patients with depression. We studied the impact of HRQoL on treatment outcome in patients with unipolar depression. Furthermore, we analysed factors associated with HRQoL in inpatients with unipolar depression. METHODS: One hundred and eighty patients suffering from major depressive disorder were evaluated during their inpatient treatment by assessing admission and discharge depression severity and their HRQoL, using the Medical Outcomes Study 12-item Short Form (SF-12). Baseline and treatment variables associated with HRQoL were examined by regression analysis. Primary outcome measures were the Hamilton Rating Scale and the Beck Depression Inventory. RESULTS: HRQoL improved significantly during inpatient treatment. Lower HRQoL outcomes were strongly associated with higher age, somatic comorbidities, a recurrent depressive disorder and stronger depressive symptoms at admission. Additionally, patients with a complex treatment situation (high number of medications, antidepressant switch) showed stronger impairment of HRQoL. Personality disorders and additional psychotherapy did not predict HRQoL. CONCLUSION: The inpatient treatment resulted in an increase of the SF-12 scores, although to a lower extent than depressive symptoms. Several factors negatively influence HRQoL, such as the presence of somatic and axis I psychiatric comorbiditites and a recurrent or severe depressive episode. Targeting somatic comorbidities in patients with unipolar depression seem to play an important role for HRQoL.
Authors: Stephen R Wisniewski; A John Rush; Charlene Bryan; Richard Shelton; Madhukar H Trivedi; Sheila Marcus; Mustafa M Husain; Steven D Hollon; Maurizio Fava Journal: J Nerv Ment Dis Date: 2007-03 Impact factor: 2.254
Authors: Madhukar H Trivedi; A John Rush; Stephen R Wisniewski; Diane Warden; William McKinney; Michael Downing; Susan R Berman; Amy Farabaugh; James F Luther; Andrew A Nierenberg; Judith A Callan; Harold A Sackeim Journal: J Clin Psychiatry Date: 2006-02 Impact factor: 4.384
Authors: Ronald C Kessler; Patricia Berglund; Olga Demler; Robert Jin; Kathleen R Merikangas; Ellen E Walters Journal: Arch Gen Psychiatry Date: 2005-06
Authors: Florian Seemüller; Michael Riedel; Michael Obermeier; Michael Bauer; Mazda Adli; Klaus Kronmüller; Florian Holsboer; Peter Brieger; Gerd Laux; Wolfram Bender; Isabella Heuser; Joachim Zeiler; Wolfgang Gaebel; Eva Dichgans; Roland Bottländer; Richard Musil; Hans-Jürgen Möller Journal: Eur Neuropsychopharmacol Date: 2010-01-22 Impact factor: 4.600
Authors: L L Judd; H S Akiskal; J D Maser; P J Zeller; J Endicott; W Coryell; M P Paulus; J L Kunovac; A C Leon; T I Mueller; J A Rice; M B Keller Journal: J Affect Disord Date: 1998-09 Impact factor: 4.839
Authors: David L. Dunner; W Jacqueline Kwong; Trisha L. Houser; Nathalie E. Richard; Rafe M. J. Donahue; Zeba M. Khan Journal: Prim Care Companion J Clin Psychiatry Date: 2001-02
Authors: Melissa J Rowthorn; D Rex Billington; Christian U Krägeloh; Jason Landon; Oleg N Medvedev Journal: Qual Life Res Date: 2019-08-10 Impact factor: 4.147
Authors: Monika Sadlonova; Julia Katharina Löser; Christopher M Celano; Christina Kleiber; Daniel Broschmann; Christoph Herrmann-Lingen Journal: Front Psychiatry Date: 2022-08-25 Impact factor: 5.435
Authors: Beatrice Bortolato; Kamilla W Miskowiak; Cristiano A Köhler; Michael Maes; Brisa S Fernandes; Michael Berk; André F Carvalho Journal: BMC Med Date: 2016-01-22 Impact factor: 8.775
Authors: Marika C Coffman; Rebecca C Shaffer; Lauren M Schmitt; Kelli C Dominick; Ernest Pedapati; Angel Wang; Elizabeth Berry-Kravis; Nicole Tartaglia; Craig A Erickson Journal: Brain Sci Date: 2020-04-04